Dizziness; Severe stomach pain; Severe pain at the injection site; Little red bump in the lip; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), ABDOMINAL PAIN UPPER (Severe stomach pain), VACCINATION SITE PAIN (Severe pain at the injection site) and LIP DISORDER (Little red bump in the lip) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included Drug allergy (Penicillin allergy) since an unknown date and Hypertension since an unknown date. Concomitant products included LISINOPRIL, VITAMIN C [ASCORBIC ACID], VITAMIN D NOS and VITAMIN E NOS for an unknown indication.    On 25-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced DIZZINESS (Dizziness), ABDOMINAL PAIN UPPER (Severe stomach pain), VACCINATION SITE PAIN (Severe pain at the injection site) and LIP DISORDER (Little red bump in the lip). On 25-Jan-2021, DIZZINESS (Dizziness) had not resolved, LIP DISORDER (Little red bump in the lip) had resolved. At the time of the report, ABDOMINAL PAIN UPPER (Severe stomach pain) and VACCINATION SITE PAIN (Severe pain at the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient stated Concomitant product including "Highseroprizer" to treat medical condition.   No treatment details were reported. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Jan-2021 and was forwarded to Moderna on 26-Jan-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), ABDOMINAL PAIN UPPER (Severe stomach pain), VACCINATION SITE PAIN (Severe pain at the injection site) and LIP DISORDER (Little red bump in the lip) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included Drug allergy (Penicillin allergy) since an unknown date and Hypertension since an unknown date. Concomitant products included LISINOPRIL, VITAMIN C [ASCORBIC ACID], VITAMIN D NOS and VITAMIN E NOS for an unknown indication.    On 25-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced DIZZINESS (Dizziness), ABDOMINAL PAIN UPPER (Severe stomach pain), VACCINATION SITE PAIN (Severe pain at the injection site) and LIP DISORDER (Little red bump in the lip). On 25-Jan-2021, DIZZINESS (Dizziness) had not resolved, LIP DISORDER (Little red bump in the lip) had resolved. At the time of the report, ABDOMINAL PAIN UPPER (Severe stomach pain) and VACCINATION SITE PAIN (Severe pain at the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient stated Concomitant product including "Highseroprizer" to treat medical condition.   No treatment details were reported.